Trial | NCT02813642  Report issue

Title

Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients
Evaluation of Non Traditional Cardiovascular Risk Factors in Chronic Kidney Disease Patients Starting Dialysis

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Recruiting

  • Intervention/Treatment

    fgf-23 protein, human ...

  • Study Participants

    400
To evaluate the relationships between bone mineral markers levels at dialysis start and vascular calcification progression during a 2 year follow up
Study Started
Dec 08
2011
Primary Completion
Dec 31
2026
Anticipated
Study Completion
Feb 28
2027
Anticipated
Last Update
Apr 14
2022

Biological Plasma osteoprotegerin level

dosage of plasma osteoprotegerin

Biological Plasma fibroblast growth factor 23 level

dosage of plasma fibroblast growth factor 23

Procedure Vascular calcification score

measurement of vascular calcification score by X-ray of the lateral abdominal aorta

Cardiovascular risk evaluation Experimental

Measurement of plasma osteoprotegerin level, plasma fibroblast growth factor 23 level, vascular calcification score and record of cardiovascular events during the 2 year follow-up

Criteria 

Inclusion Criteria:

Patient who has signed the written consent form
Patient with chronic renal failure starting dialysis therapy

Exclusion Criteria:

Pregnancy
Patient with chronic renal failure not yet on dialysis therapy
No Results Posted